Intelligent Bio Solutions (INBS) Shares Outstanding (Diluted Average) (2022 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly Shares Outstanding (Diluted Average) of $5.3 million in Q2 2025, up 1022.41% quarter-over-quarter from $469849.0 in Q1 2025, and up 231.1% on a YoY basis from $1.6 million in Q2 2024.
Intelligent Bio Solutions (INBS) Shares Outstanding (Diluted Average) (2022 - 2025) Analysis & Trends
Intelligent Bio Solutions' Shares Outstanding (Diluted Average) history runs 4 years deep, the most recent figure standing at $5.3 million for Q2 2025.
- In Q2 2025, Shares Outstanding (Diluted Average) rose 231.1% year-over-year to $5.3 million; the TTM figure through Jun 2025 stood at $5.3 million (up 231.1% YoY), while the FY2025 annual figure was $5.3 million, up 231.1% from the prior year.
- Shares Outstanding (Diluted Average) was $5.3 million for Q2 2025 at Intelligent Bio Solutions, up from $469849.0 in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $5.3 million in Q2 2025 to a low of $68866.0 in Q4 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $1.2 million across 4 years, with a median of $733263.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) tumbled 88.58% in 2023, then soared 1862.46% in 2024.
- A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $68866.0 in 2022, then jumped by 1279.0% to $949660.0 in 2023, then sank by 56.05% to $417345.0 in 2024, then jumped by 1163.62% to $5.3 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $5.3 million (Q2 2025), $469849.0 (Q1 2025), and $417345.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 580.70 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 457.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 393.60 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Intelligent Bio Solutions | 12.72 Mn | 11.52 Mn | - | 5.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 5.27 Mn |
| Mar 31, 2025 | 469,849.00 |
| Dec 31, 2024 | 417,345.00 |
| Sep 30, 2024 | 3.81 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 949,660.00 |
| Sep 30, 2023 | 194,200.00 |
| Jun 30, 2023 | 83,717.00 |
| Mar 31, 2023 | 76,629.00 |
| Dec 31, 2022 | 68,866.00 |
| Sep 30, 2022 | 744,495.00 |
| Jun 30, 2022 | 733,263.00 |